col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


109 Ergebisse       Seite 1

 [1] 
Elsevier: Vacunas (English Edition)
  Original Artikel Datum Titel Autoren   Max. 6 Autoren
1 [GO] 2025―Mai―29 Exploring structural proteins of Nipah, Lassa, and coronaviruses for multi-epitope vaccine design using immuno-informatics and in silico studies Ananya Saji, Sagaya Jansi Rozario, Balamurugan Shanmugaraj, Praveen Kumar Panthagani
2 [GO] 2025―Mai―29 Shaping health behavior and social connectedness during COVID-19 through media adaptation strategies in Indonesia Muhammad Saud, Irfan Wahyudi
3 [GO] 2025―Apr―02 COVID-19 story: Entry and immune response Ali Mohammed Ashraf, Marwan Y. Al-Maqtoofi, Ahmed A. Burghal
4 [GO] 2025―Apr―02 Evaluation of the effect of melatonin on patients with COVID-19 admitted to ICU: A double-blind randomized clinical trial Mahmoud Ganjifard, Shokouh Ghafari, Adeleh Sahebnasagh, Mahboubeh Esmaeili, Ali Reza Amirabadizadeh, Azadeh Ebrahimzadeh, Parvin Askari, Razieh Avan
5 [GO] 2025―Apr―01 Artificial intelligence and COVID-19 vaccine hesitancy Sara Kamal Shahsavar, Arman Alinezhad, Masoud Keikha
6 [GO] 2024―Nov―14 Association of C4 and CH50 levels with cough and rhinorrhea in COVID-19 patients: A retrospective analysis in the Iranian population Seyed Ali Hashemi, Forouzan Rostami, Babak Shaghaghi, Mahla Niknam, Elham Abani, Abdol Sattar Pagheh, Arezou Khosrojerdi, Fatemeh Rezaei
7 [GO] 2024―Nov―14 Psychological characteristics and their impact on the efficacy and safety of COVID-19 vaccines Mohsen Karbalaei, Vahideh Poyesh, Masoud Keikha
8 [GO] 2024―Aug―29 Post COVID-19 era: Re-emergence of known and future (X) viral pathogens Pryanka Thakur, Vikram Thakur, Monika Sapra, Sonakshi Srivastava, Sanjay Kumar Singh Patel
9 [GO] 2024―Aug―29 Social media as a supporting mechanism during COVID-19 in Indonesia: A quantitative study on isolation among elders Mustain Mashud, Muhammad Saud, Rachmah Ida, Asia Ashfaq
10 [GO] 2024―Aug―29 Musculoskeletal and neuromuscular dysfunction due to covid-19 infection: A review Vivek Chauhan, Akash Pandey, Adrija Rakshit, Gaytri Mahajan, Shamsher S. Kanwar, Vivek Kumar Dhiman, Devendra Singh
11 [GO] 2024―Aug―29 COVID-19 vaccination and concerns regarding the maternal and neonatal safety outcomes Abdolreza Narouiepour, Mohsen Karbalaei, Masoud Keikha
12 [GO] 2024―Aug―29 COVID-19 vaccine rumour and resistance in Indonesia: Analysing vaccine hesitancy and cultural myths circulated on online platforms Rachmah Ida, Sri Endah Kinasih, Syafrida Nurrachmi Febriyanti, Ratih Puspa, Muhammad Saud, Mohd Syuhaidi Abu Bakar
13 [GO] 2024―Aug―01 SARS-CoV-2 vaccination effect over coagulation in 60s patients treated with acenocumarol Isabel Almodóvar-Fernández, Antonio Real-Fernández, Manuel Jesús Romero Atanes, Carlos Andreu-Vilarroig, Miguel Ángel Beltrán-Viciano, María Francisca Monreal-Pérez
14 [GO] 2024―Jul―31 Importance of national regulatory agencies and national control laboratories in the face of the COVID-19 pandemic: Experience of Federal Commission for the Protection against Sanitary Risks (COFEPRIS) Imelda Rocío Guzmán-Cervantes, Elías Parra-Hernández, Alejandro Ernesto Svarch-Pérez, Armida Zúñiga-Estrada, Jorge C. Alcocer-Varela
15 [GO] 2024―Jun―15 Knowledge, attitudes, and adherence of the Cape Verdean population to the COVID-19 vaccine Maria de Fátima Carvalho Alves, Janice de Jesus Soares, Maria da Luz Lima Mendonça
16 [GO] 2024―Jun―15 Analysis of the level of protective serum antibody after third dose of different COVID-19 vaccines Atena Mansouri, Mitra Rafiee, Seyed-Alireza Esmaeili, Saboura Nikpour, Alireza Fereidouni, Mohammad Fereidouni
17 [GO] 2024―Jun―15 Innate and adaptative immune mechanisms of COVID-19 vaccines. Serious adverse events associated with SARS-CoV-2 vaccination: A systematic review Rocío Morlanes Pallás
18 [GO] 2024―Jun―15 The impact of Omicron on the COVID-19 vaccines: A review Pragya D. Yadav, Deepak Y. Patil, Rima R. Sahay, Anita M. Shete, Sreelekshmy Mohandas, Velu Nair
19 [GO] 2024―Jun―15 The co-infection of SARS-CoV-2 with atypical bacterial respiratory infections: A mini review Fateme Taheri, Soheil Vesal, Parnian Goudarzi, Zahra Sahafnejad, Amin Khoshbayan
20 [GO] 2024―Mai―10 COVID-19 vaccination and web search on mental health: A worldwide infodemiological study Juan Antonio Becerra-García, Sara Barbeito, Teresa Sánchez-Gutiérrez
21 [GO] 2024―Mrz―14 Exploring the psychological impact of anxiety, depression, and quality of life in patients with comorbid disease conditions post COVID-19 pandemic era Anmar Al-Taie, Dania A. Mohd Khalaf, Oritsetimeyin Arueyingho
22 [GO] 2024―Mrz―14 Attitudes and concerns of Turkish nursing students against the COVID-19 vaccine, willingness to be vaccinated: A cross-sectional study Zeynep Daşıkan, Mashood Katuntu Waiswa
23 [GO] 2024―Mrz―14 COVID-19 vaccines, perceptions and trust amongst vaccine refusers: A qualitative thematic analysis study Deldar Morad Abdulah, Hawar Abdulrazaq Mohammedsadiq, Pranee Liamputtong
24 [GO] 2024―Mrz―14 The prevalence of post-COVID-19 vaccination syndrome and quality of life among COVID-19-vaccinated individuals Yogendra Shrestha, Rajesh Venkataraman
25 [GO] 2024―Mrz―14 Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform Fahime Edalat, Fatemeh Hosseini Tabatabaie, Afagh Moattari, Arash Letafati, Jamal Sarvari, Seyed Younes Hosseini
26 [GO] 2024―Mrz―14 Vaccination impact on long COVID sequelae; a perspective view Farhad Dadgar, Fatemeh Dehghani, Farzaneh Peikfalak, Masoud Keikha
27 [GO] 2024―Mrz―07 Genetic variants rs1800629 in TNF and rs2228145 in IL6R: Association with adverse event following immunisation (AEFI) and SARS-CoV-2 neutralising antibodies in western Mexico population that received AZD1222 vaccine Axel Jair Villa-Panduro, Narda M. Corona-Reynaga, Dennis A. Meza-Peña, Mayra Alejandra Enciso Ramírez, Astrid Selene Espinoza García, Jorge Galindo-García, Berenice Sanchez-Caballero, Elia Herminia Valdés-Miramontes, José Francisco Muñoz-Valle, Zyanya Reyes-Castillo
28 [GO] 2023―Nov―27 Impact of vaccination on the entire population and dose-response relation of COVID-19 Abdul Malek, Ashabul Hoque
29 [GO] 2023―Nov―27 COVID-19 immune response in adults post Measles-Rubella vaccination Suwoyo Suwoyo, Erna Rahma Yani, Koekoeh Hardjito
30 [GO] 2023―Nov―27 To assess mortality from COVID-19 in patients with comorbidities, it is crucial to perform an autopsy Josef Finsterer
31 [GO] 2023―Nov―27 Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran Canaria Alejandro de Arriba Fernández, José Luis Alonso Bilbao, Alberto Espiñeira Francés, Antonio Cabeza Mora, Ángela Gutiérrez Pérez, Miguel Ángel Díaz Barreiros
32 [GO] 2023―Nov―27 Adverse events following COVID-19 vaccination among pregnant women attending primary health centers: An active-surveillance study Narayana Goruntla, Basappa Karisetty, Nandini Nandini, Bharadwaj Bhupasamudram, Himaja Reddy Gangireddy, Kasturi Vishwanathasetty Veerabhadrappa, Joseph Obiezu Chukwujekwu Ezeonwumelu, Vishnuvandana Bandaru
33 [GO] 2023―Nov―27 The polymorphisms of TNF-α related-gene and antibody production following third dose of COVID-19 vaccination: A pilot study Phey Liana, Zen Hafy, Soilia Fertilita, Ella Amalia, Veny Larasati, Tungki Pratama Umar
34 [GO] 2023―Nov―27 Exploring the intention and hesitancy to receive a booster dose of COVID-19 vaccine among patients with comorbid disease conditions using a health belief model Anmar Al-Taie, Zekiye Yilmaz
35 [GO] 2023―Nov―07 Autumn 2023 SARS-CoV-2 immunization: Who should be vaccinated and how? Fernando Moraga-Llop, Magda Campins-Martí
36 [GO] 2023―Nov―07 Impact of vaccination in the mortality of Colombian adults with acute respiratory distress syndrome due to SARS-CoV-2 who required invasive mechanical ventilation Yina Daniela Benítez Patiño, Luis Carlos Triana, Oscar Mauricio Muñoz Velandia, Viviana Yiset López Ramírez, Laura María Niño Guerra, Santiago Bottia Córdoba
37 [GO] 2023―Jul―18 Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece Petros Galanis, Aglaia Katsiroumpa, Irene Vraka, Vanessa Chrysagi, Olga Siskou, Olympia Konstantakopoulou, Theodoros Katsoulas, Parisis Gallos, Daphne Kaitelidou
38 [GO] 2023―Jul―18 Demographic and clinical characteristics and outcomes of COVID-19 patients admitted to a university hospital in the west of Iran: a retrospective study in the third wave Younes Jesmani, Arezoo Bozorgomid, Fatemeh Khosravi Shadmani, Ali Dehbani, Babak Sayad
39 [GO] 2023―Jul―18 Incidence of sudden sensorineural hearing loss associated with BNT162b2 COVID-19 vaccine: Pooled results from register-based nationwide studies Paulo Ricardo Martins-Filho
40 [GO] 2023―Jul―18 The status of COVID-19 vaccines in India: A review Deepak Kumar Jha, Kumar Pranay, Amit Kumar, Niti Yashvardhini
41 [GO] 2023―Jul―18 An immunoinformatics approach to study the epitopes of SARS-CoV-2 helicase, Nsp13 Sushant Kumar, Khushboo Kumari, Gajendra Kumar Azad
42 [GO] 2023―Jun―25 Factores asociados a la intención de vacunación contra el COVID-19 en Popayán, Cauca, Colombia Omar Andrés Ramos Valencia, Yuliana Buitrón Gonzalez, Jorge Sotelo Daza, Andrés Felipe Villaquiran
43 [GO] 2023―Jun―25 IMPACT OF VACCINATION AGAINST SARS-CoV-2 ON THE INCIDENCE OF INFECTION IN SCHOOL SETTINGS. María Teresa Herrero Diez, María Inés Salado Valdivieso, Sara Carbajal Domínguez, Marta Allué Tango, Juan Carlos Villa Caballero, Clara Berbel Hernández
44 [GO] 2023―Mai―17 The End of COVID-19 Public Health Emergency of International Concern (PHEIC): And Now What? Núria Torner
45 [GO] 2023―Mai―04 Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study Fazlollah Shokri, Saeed Rezapoor, Masoud Najafi, Mohsen Asadi, Mohammad Karimi alavije, Moussa Abolhassani, Mohammad Hossein Moieneddin, Amir Muhammad Ashrafi, Narges Gholipour, Parisa Naderi, Jamshid Yazdani Charati, Reza Alizadeh-Navaei, Majid Saeedi, Mohsen Heidary, Mostafa Rostamnezhad
46 [GO] 2023―Mai―04 Differences in elderly stress levels before Covid-19 vaccination: History of exposure to Covid-19 reduces stress before vaccination Kristian Budi Setiawan, Isna Hikmawati, Dita Pratiwi Kusuma Wardani, Juanita Juanita
47 [GO] 2023―Mai―04 Knowledge and attitudes toward the COVID-19 vaccine among India's general rural population Rajesh Venkataraman, Umesh Yadav, Yogendra Shrestha, Sindhushree Narayanaswamy, Shree Harsha Pura Basavaraju
48 [GO] 2023―Mai―04 Optic neuritis associated with COVID-19-related vaccines Masoud Keikha, Mehdi Zandhaghighi, Shahram Shahraki Zahedani
49 [GO] 2023―Mrz―24 Vaccination against COVID-19 from 6 months of age on. Completing the circle of prevention in paediatrics. Fernando Moraga-Llop
50 [GO] 2023―Feb―27 The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19 Ali AliMohammadi, Nahid Chezani-sharahi, Zahra Asgari Hezaveh, Elnaz Abbasi, Aref Shariati, Ehsanollah Ghaznavi-Rad
51 [GO] 2023―Feb―27 Vaccine hesitancy and the challenge of controlling COVID-19 and other vaccine-preventable diseases Paulo Ricardo Martins-Filho
52 [GO] 2023―Feb―27 Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study Seyede Faezeh Mousavi, Mohammadamin Ebrahimi, Seyed Amirhosein Ahmadpour Moghaddam, Narges Moafi, Mahbobe Jafari, Ayoub Tavakolian, Mohsen Heidary
53 [GO] 2023―Feb―27 Parents' perception of COVID-19 risk of infection and intention to vaccinate their children Hamdy Khaled Sabra, Mostafa Abdulraheem Bakr, Omar El Sayed Mohmed Rageh, Asmaa Khaled, Omnia Mohamed Elbakliesh, Ibrahim Ali Kabbash
54 [GO] 2023―Feb―27 Multivalent vaccines against new SARS-CoV-2 hybrid variants Kiarash Ghazvini, Masoud Keikha
55 [GO] 2023―Feb―27 Determination of binding affinity of tunicamycin with SARS-CoV-2 proteins: Proteinase, protease, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, envelope and RBD of spike glycoprotein Ali Adel Dawood
56 [GO] 2022―Nov―24 Comparison of clinical, radiological and laboratory findings in discharged and dead patients with COVID-19 Mahbobe Jafari, Maryam Akbari, Maryam Navidkia, Shirin Dashtbin, Seyede Faezeh Mousavi, Mohsen Heidary, Saeed Khoshnood
57 [GO] 2022―Nov―24 Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain Christine Giesen, Carmen Saa-Requejo, Inmaculada Lopez-Carrillo, Angelica Ortega-Torres, Cristina García-Fernández
58 [GO] 2022―Nov―24 COVID-19 vaccination acceptance in Jambi City, Indonesia: A single vaccination center study Gilbert Sterling Octavius, Theo Audi Yanto, Rivaldo Steven Heriyanto, Haviza Nisa, Catherine Ienawi, H. Emildan Pasai
59 [GO] 2022―Nov―24 Intention to get COVID-19 vaccination and its associated predictors: A cross-sectional study among the general public in Algeria Mohamed Lounis, Samir Abdelhadi, Mohammed Amir Rais, Djihad Bencherit, Malik Sallam
60 [GO] 2022―Nov―24 COVID-19 vaccination coverage and associated factors in seasonal fruit workers in Lleida Carme Miret, Miquel Alsedà, Pere Godoy
61 [GO] 2022―Nov―24 Lack of COVID-19 vaccination in rural areas of Pakistan Alisha Saleem, Maha Rashid, Ameerah Shaikh, Sajjad Ali
62 [GO] 2022―Nov―24 Reasons for individuals' COVID-19 vaccine hesitations and changing decisions over time: A longitudinal qualitative study Dicle Filiz Yıldırım, Pınar Serçekuş, Sevgi Özkan
63 [GO] 2022―Nov―24 Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece Petros Galanis, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Ioannis Moisoglou, Daphne Kaitelidou
64 [GO] 2022―Nov―24 The prevalence of inverse health consequences of COVID-19 vaccines: A post-vaccination study Yogendra Shrestha, Rajesh Venkataraman
65 [GO] 2022―Nov―24 Menstrual abnormalities after COVID-19 vaccines: A systematic review Maheen Nazir, Shumaila Asghar, Muhammad Ali Rathore, Asima Shahzad, Anum Shahid, Alishba Ashraf Khan, Asmara Malik, Tehniat Fakhar, Hafsa Kausar, Jahanzeb Malik
66 [GO] 2022―Nov―24 COVID-19 vaccines: Update of the vaccines in use and under development Rafaela Angotti Marta, Gisele Emy Kondo Nakamura, Bruno de Matos Aquino, Paulo R. Bignardi
67 [GO] 2022―Nov―24 Early diagnosis and treatment of SARS-CoV-2 vaccination associated polyradiculitis improves outcome Josef Finsterer, Fulvio A. Scorza
68 [GO] 2022―Nov―24 Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? Masoud Keikha
69 [GO] 2022―Nov―24 Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants Ali Adel Dawood
70 [GO] 2022―Okt―28 Mass vaccinations against COVID-19 through the use of technologies for the management of appointment scheduling and data of large volumes of vaccinated Alicia K. Rodas-Martinez, Josue R. Altamirano-Yupanqui
71 [GO] 2022―Sep―14 Assessment of attitude and hesitancy toward vaccine against COVID-19 in a Pakistani population: A mix methods survey Z.A. Khan, R. Allana, I. Afzal, A.S. Ali, O. Mariam, R. Aslam, I.A. Shah, A. Allana, M.M. Haider, R. Jandani, Z. Khan, A.M. Siddiqui, J.A. Shah, U. Butt
72 [GO] 2022―Sep―14 Factors influencing the acceptability of COVID-19 vaccination: A cross-sectional study from Malaysia R.R. Marzo, A. Ahmad, K. Abid, A.P. Khatiwada, A. Ahmed, T.M. Kyaw, I.B.Z. Abidin, M. Srithar, S. Sinnathamby, A.P. Sarvasundram, S. Shrestha
73 [GO] 2022―Sep―14 Awareness, knowledge and acceptance of COVID-19 vaccine among the people of West Bengal, India: A web-based survey Sovan Samanta, Jhimli Banerjee, Suvrendu Sankar Kar, Kazi Monjur Ali, Biplab Giri, Amitava Pal, Sandeep Kumar Dash
74 [GO] 2022―Sep―14 Predictive demographic factors of Covid-19 vaccine hesitancy in Venezuela: A cross-sectional study G. Andrade
75 [GO] 2022―Sep―14 Attitudes of a sample of Jordanian young adults toward different available COVID-19 vaccines W. Al-Qerem, A.S. Jarab, R. Qarqaz, M.A. Hayek
76 [GO] 2022―Sep―14 Adenoviral vector-based COVID-19 vaccines-associated cerebral venous sinus thromboses: Are those adverse events related to the formation of neutrophil extracellular traps? Marian Simka
77 [GO] 2022―Sep―14 Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies Niti Yashvardhini, Amit Kumar, Deepak Kumar Jha
78 [GO] 2022―Aug―12 Zinc role in Covid-19 disease and prevention A. Boretti, B.K. Banik
79 [GO] 2022―Aug―12 Selection of new COVID-19 genotypes following mass vaccination: The Rotavirus model Pierfrancesco Lapolla, Pietro Familiari, Placido Bruzzaniti
80 [GO] 2022―Aug―12 Is there any effect of flu vaccine on the SARS-CoV-2 infected patients? D. El-Qutob, M. Nieto, L. Alvarez-Arroyo, F.J. Carrera-Hueso
81 [GO] 2022―Aug―12 Discordant results of SARS-CoV-2 PCR-based tests in the early phase of pandemic in Indonesia: Infection control consequences A. Pranata, B. Zulkifli, S.F. Santosa, A. Oktiviyari, Z. Zulfitri, Z. Hayati, M. Mudatsir, I. Ichsan, H. Harapan
82 [GO] 2022―Jul―20 Paediatric vaccination against COVID-19 beyond adolescence. Another reality F. Moraga-Llop
83 [GO] 2022―Jul―11 Management of the COVID-19 pandemic in Catalonian geriatric nursing homes F.E.R.N.A.N.D.O. PARRILLA
84 [GO] 2022―Jul―01 Association between influenza vaccination and mortality due to COVID-19 C.A. Arce-Salinas, Y.N. Esquivel-Torruco, A.A. Bejarano-Juvera, A.K. Bustamante-Flores, N. Aguilar-Martínez, J.G. Azcorra-López, B. Cabañas-Espinosa, E.M. Luna-Rivera, A. Hernández-Alarcón, J. Reyna Figueroa
85 [GO] 2022―Mai―26 ASSESSMENT OF THE HUMORAL IMMUNITY INDUCED BY SPUTNIK V COVID-19 VACCINE (GAM-COVID-VAC) IN HEALTHCARE WORKERS Ezequiel Cordova, M. Ines Lespada, Diego Cecchini, Fabiola Nieto, Susana Palonski, Mariana Badran, Silvina Bernasconi, Brenda Bacelar, Laura Morganti, Franco Garibaldi, Veronica Bermejo, Viviana Aguirre, Marcela Badia, Claudia G. Rodriguez
86 [GO] 2022―Mai―20 Diagnosis of COVID-19 in symptomatic patients: An updated review M.N. Zahan, H. Habibi, A. Pencil, J. Abdul-Ghafar, S.A. Ahmadi, N.S. Juyena, M.T. Rahman, M.S. Parvej
87 [GO] 2022―Mai―18 Willingness to receive the COVID-19 vaccine in the population aged 80 years and older in Colombia 2021 N. Alvis-Guzman, J. Alvis-Zakzuk, J. Paz-Wilches, J.C. Fernandez-Mercado, F. de la Hoz-Restrepo
88 [GO] 2021―Okt―30 COVID-19 and primary care: A perspective from Italy F. Ghidinelli, F. Martire
89 [GO] 2021―Okt―30 Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021 N. Alvis-Guzman, J. Alvis-Zakzuk, J. Paz-Wilches, J.C. Fernandez-Mercado, F. de la Hoz-Restrepo
90 [GO] 2021―Okt―22 SARS-CoV-2 variants, a still unfinished story M. Pérez-Abeledo, J.C. Sanz Moreno
91 [GO] 2021―Okt―12 SEPAR recommendations and new challenges on COVID-19 vaccine in respiratory diseases D. de la Rosa-Carrillo, J.L. López-Campos, M. Blanco Aparicio, F. Villar-Álvarez
92 [GO] 2021―Okt―08 Vaccination against COVID-19 in adolescents. A reality F. Moraga-Llop
93 [GO] 2021―Jun―23 How will the second wave of the dreadful COVID-19 be with the increasing number of the infected cases and mortality in Iraq? A.A. Dawood, Z.A. Dawood
94 [GO] 2021―Jun―23 The future role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic A. La Gatta, F. Ghidinelli
95 [GO] 2021―Jun―23 Novel coronavirus 2019 (COVID-19) pandemic outbreak: A comprehensive review of the current literature H. Ullah, A. Ullah, A. Gul, T. Mousavi, M.W. Khan
96 [GO] 2021―Jun―23 Myths and conspiracy theories on vaccines and COVID-19: Potential effect on global vaccine refusals I. Ullah, K.S. Khan, M.J. Tahir, A. Ahmed, H. Harapan
97 [GO] 2021―Jun―23 Retrospective and prospective application of robots and artificial intelligence in global pandemic and epidemic diseases A. Yoganandhan, G. Rajesh Kanna, S.D. Subhash, J. Hebinson Jothi
98 [GO] 2021―Jun―11 Impact of spike genetic variants in vaccines against SARS-CoV-2 J. Reina, P. Fraile-Ribot
99 [GO] 2021―Jun―09 Governments and vaccination against COVID-19 L.A. Javier Silva, E.A. Rosario Pacahuala
100 [GO] 2021―Jun―01 The vaccine-condition or vaccination passport and its eventual fit into a broad recommended vaccination framework against COVID-19 C. Cierco Seira
101 [GO] 2021―Feb―16 Glycosylation, ligand binding sites and antigenic variations between membrane glycoprotein of COVID-19 and related coronaviruses Ali A. Dawood
102 [GO] 2021―Feb―16 Epidemic trends of COVID-19 in 10 countries compared with Turkey V. Durmuş
103 [GO] 2021―Feb―16 Intractable airsickness associated with COVID-19: A case report H. Talebi Bezmin Abadi, A.T.B. Abadi, A.A. Farahani, M. Darvishi
104 [GO] 2020―Nov―27 A review on Promising vaccine development progress for COVID-19 disease Tafere Mulaw Belete
105 [GO] 2020―Nov―27 Collateral effects of Covid-19 pandemic emergency response on worldwide immunizations N. Torner
106 [GO] 2020―Nov―27 Are social distancing, hand washing and wearing masks appropriate measures to mitigate transmission of COVID-19? N. Manikandan
107 [GO] 2020―Okt―19 Recovering vaccine coverage lost due to the COVID-19 pandemic F.A. Moraga-Llop, M. Fernández-Prada, A.M. Grande-Tejada, L.I. Martínez-Alcorta, D. Moreno-Pérez, J.J. Pérez-Martín
108 [GO] 2020―Jun―29 Coronavirus vaccines L. Urbiztondo, E. Borras, G. Mirada
109 [GO] 2020―Mai―08 The SARS-CoV-2, a new pandemic zoonosis that threatens the world J. Reina
 [1] 

109 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec